Adam Baker PhD

Adam leads the Human Health and Microbiome Research and Development team who are responsible for the research of current and next-generation probiotics, and the development of technology in vitro and in vivo discovery platforms for a mode of action research. Prior to Chr. Hansen, Adam worked as the VP of Diagnostic Product Development at Exiqon A/S in Denmark for five years and the Head of New Technologies in deCODE Genetics in Iceland. Both roles focused on the development of new insights and therapeutics to support the clinical treatment of complex diseases.